Latest Breaking News On - Inken becker - Page 1 : comparemela.com

LumiThera Presents Valeda Treatment Benefits for Photobiomodulation in Early Patients with Diabetic Retinopathy and Macular Edema

LumiThera Presents Valeda Treatment Benefits for Photobiomodulation in Early Patients with Diabetic Retinopathy and Macular Edema USA - English Share this article Share this article SEATTLE, May 7, 2021 /PRNewswire/ LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular damage and diseases, today announced research investigators lead by Drs. Hakan Kaymak, Inken Becker and Hartmut Schwahn, from the Macula Retina Centre of Breyer Kaymak & Klabe Eye Clinic in Dusseldorf, Germany presented positive clinical findings following PBM treatment with the Valeda Light Delivery System from an ongoing safety and efficacy study in Early Diabetic Retinopathy (DR) Patients with Central Macular Edema (DME) at the Association for Research in Vision and Ophthalmology Conference 2021.

United statesClark tedfordHakan kaymakHartmut schwahnMarion munkInken beckerResearch at hakan kaymakUniversity hospital bernLumithera incEuropean unionAssociation for researchBern photographic reading centerFood drug administrationMacula retina centreBreyer kaymakKlabe eye clinic

LumiThera Presents Valeda Treatment Benefits for Photobiomodulation in Early Patients with Diabetic Retinopathy and Macular Edema

LumiThera Presents Valeda Treatment Benefits for Photobiomodulation in Early Patients with Diabetic Retinopathy and Macular Edema News provided by Share this article Share this article SEATTLE, May 7, 2021 /CNW/ LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular damage and diseases, today announced research investigators lead by Drs. Hakan Kaymak, Inken Becker and Hartmut Schwahn, from the Macula Retina Centre of Breyer Kaymak & Klabe Eye Clinic in Dusseldorf, Germany presented positive clinical findings following PBM treatment with the Valeda Light Delivery System from an ongoing safety and efficacy study in Early Diabetic Retinopathy (DR) Patients with Central Macular Edema (DME) at the Association for Research in Vision and Ophthalmology Conference 2021.

United statesClark tedfordHakan kaymakHartmut schwahnMarion munkInken beckerResearch at hakan kaymakUniversity hospital bernLumithera incEuropean unionAssociation for researchBern photographic reading centerFood drug administrationMacula retina centreBreyer kaymakKlabe eye clinic

LumiThera présente les bénéfices du traitement par photobiomodulation utilisant le système Valeda chez les patients atteints de rétinopathie diabétique précoce avec œdème maculaire

LumiThera présente les bénéfices du traitement par photobiomodulation utilisant le système Valeda chez les patients atteints de rétinopathie diabétique précoce avec œdème maculaire
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Marion munkInken beckerResearch in visionLight valedaCentral regionProfessor marion munkBern photographic readingRelated links lead lumitheraமரியன் மஂக்மைய பகுதிபெர்ன் புகைப்பட ரீடிஂக்